期刊文献+

阿霉素诱导大鼠扩张型心肌病模型的建立 被引量:12

Adriamycin-induced dilated cardiomyopathy model of rat
下载PDF
导出
摘要 目的建立稳定可靠的扩张型心肌病(dilated cardiomyopathy,DCM)动物模型,以供基础实验研究。方法选用雄性Wistar大鼠,分为正常对照组和DCM模型组,DCM组接受腹腔注射生理盐水溶解的阿霉素2.5 mg/(kg.week),稀释浓度1 mg/ml;正常组腹腔注射等量生理盐水。每周根据体重调整阿霉素剂量,用药6周后,停药观察2周。记录大鼠体重的变化及死亡率,检查超声心动图检查、血浆脑利钠肽(BNP)水平、测量左心室内径、观察心肌病理切片、电镜、Masson染色结果。结果DCM模型组体重增长缓慢,低于正常对照组,出现死亡。心脏超声心动图示模型组左室舒张期末径(left ventricular end diastolic diameter,LVEDD)、左室收缩期末径(left ventricular end systolic diameter,LVESD)和左室射血分数(left ventricular ejection fraction,LVEF)、左室短轴缩短率(fraction shortening,FS)。各项指标明显低于正常对照组,P<0.01。模型组大鼠血浆BNP水平高于正常对照组,P<0.01。模型组左心室内径大于正常对照组P<0.01。心肌病理切片、电镜观察、Masson染色结果符合DCM改变。结论该制造扩张型心肌病动物模型的方式方法成功率高,造模周期较短,结果可靠,可以做为基础研究的动物模型。 Objective To establish a stable and reliable animal models with dilated cardiomyopathy (dilated cardiomyopathy, DCM) for basic experiments.Methods Male Wistar rats were divided into normal control group and DCM model group,DCM group received intraperitoneal injection of saline soluble doxorubicin 2.5 mg/(kg. week), dilute the concentration of 1 mg/ml; normal group, intraperitoneal injection, tales doses volume of normal saline. Weekly according to body weight adjusted dose of doxorubicin, medication 6 weeks after the withdrawal observed 2 weeks. Records of body weight changes and mortality, Check echocardiography, plasma brain natriuretic peptide (BNP) levels, left ventricular diameter, myocardial pathology, electron microscopy. Results DCM model group, the slow weight gain, lower than the control group,. Model of cardiac echocardiography shows left ventricular end dias- tolic diameter( LVEDD), left ventrieular end systolic diameter, (LVESD) and left ventricular ejection fraction (LVEF), left ventricular fractional shortening (b-S). The index was significantly lower than the control group, P 〈 0.01. Model group, plasma BNP levels higher than the normal control group, P 〈 0.01. Model group, left ventricular internal diameter greater than the normal control group, P 〈 0.01. Myocardial pathology, electron microscopy, results in line with DCM to change. Conclusion The way of make animal model of dilated cardiomyopathy has high success rate, short-cycle modeling and reliable results. It can serve as animal models for basic research.
出处 《中国实验诊断学》 北大核心 2010年第3期331-334,共4页 Chinese Journal of Laboratory Diagnosis
关键词 阿霉素 扩张型心肌病 adrianlycin dilated cardiomyopathy
  • 相关文献

参考文献12

  • 1Cardiovascular toxicity associated with cancer treatment. Viale PH, Yamamoto DS[J]. Clin J Oncol Nurs,2008,12(4) :627.
  • 2Ink A, Ahn E, Soor GS, et al. Dilated cardiomyopathy: a review[ J]. J Clin Pathol,2009,62(3) :219.
  • 3Recchia FA, Lionetti V. Animal models of dilated cardiomyopathy for translational research[J] .Vet Res Commun,2007,31 (Suppl 1):35.
  • 4黄荣杰,刘唐威,伍伟锋,庞玉生.呋喃唑酮制备大鼠扩张型心肌病模型[J].中国病理生理杂志,2005,21(11):2147-2150. 被引量:28
  • 5邓海,龚云,曾晶晶.小剂量阿霉素间断静注诱导兔扩张型心肌病模型的实验研究[J].今日药学,2008,18(3):80-82. 被引量:4
  • 6Nithipongvanitch R, Ittarat W, Cole MP, et al. Mitochondrial and nuclear p53 localization in eardiomyocytes: redox modulation by doxombicin ( Adriamyein ) ? [ J ]. Antioxid Redox Signal, 2007,9 ( 7 ) : 1001.
  • 7Berthiaume JM, Wallace KB. Adriamycin-induced oxidative mitochondrial cardiotoxicity [ J ]. Cell Biol Toxicol, 2007,23 ( 1 ) : 15.
  • 8Viale PH, Yamamoto DS. Cardiovascular toxicity associated with cancer treatment[J]. Clin J Oncol Nurs,2008,12(4) :627.
  • 9Hayward R, Hydock DS. Doxorubicin cardiotoxicity in the rat: an in vivo characterization[J] .J Am Assoc Lab Anim Sci,2007,46(4):20.
  • 10Yi X, Bekeredjian R, DeFilippis NJ, Siddiquee Z, et al. Transcriptional analysis of doxorubicin-induced cardiotoxicity [ J]. Am J Physiol Heart Circ Physiol, 2006,290(3) : H1098.

二级参考文献10

共引文献40

同被引文献105

引证文献12

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部